Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra J Vandenberg

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Blood|January 24, 2013
ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopeniaCassandra J Vandenberg, Suzanne Cory
The EMBO Journal|December 18, 2002
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chainsDonna L Mallery, Cassandra J Vandenberg, Kevin Hiom
Blood|July 3, 2014
Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrainedCassandra J Vandenberg, Paul Waring, Andreas Strasser, et al.
Molecular Biology and Evolution|July 26, 2002
Variant subunit specificity in the quaternary structure of Artemia hemoglobinCassandra J Vandenberg, Charles M Matthews, Clive N A Trotman
Nature Genetics|August 24, 2005
The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repairWendy L Bridge, Cassandra J Vandenberg, Roger J Franklin, et al.
Cell Death and Differentiation|February 9, 2023
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesisHai Vu Nguyen, Cassandra J Vandenberg, Mikara R Robati, et al.
Cell Death and Differentiation|August 12, 2017
Mnt modulates Myc-driven lymphomagenesisKirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al.
Cell Reports|March 8, 2016
Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to ApoptosisStephanie Grabow, Alex R D Delbridge, Brandon J Aubrey, et al.
Frontiers in Genetics|September 26, 2022
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune systemNirashaa T Bound, Cassandra J Vandenberg, Apriliana E R Kartikasari, et al.
Molecular Cancer Research : MCR|April 17, 2021
CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP InhibitorsZhen Xu, Cassandra J Vandenberg, Elizabeth Lieschke, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Blood|January 24, 2013
ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopeniaCassandra J Vandenberg, Suzanne Cory
The EMBO Journal|December 18, 2002
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chainsDonna L Mallery, Cassandra J Vandenberg, Kevin Hiom
Blood|July 3, 2014
Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrainedCassandra J Vandenberg, Paul Waring, Andreas Strasser, et al.
Molecular Biology and Evolution|July 26, 2002
Variant subunit specificity in the quaternary structure of Artemia hemoglobinCassandra J Vandenberg, Charles M Matthews, Clive N A Trotman
Nature Genetics|August 24, 2005
The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repairWendy L Bridge, Cassandra J Vandenberg, Roger J Franklin, et al.
Cell Death and Differentiation|February 9, 2023
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesisHai Vu Nguyen, Cassandra J Vandenberg, Mikara R Robati, et al.
Cell Death and Differentiation|August 12, 2017
Mnt modulates Myc-driven lymphomagenesisKirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al.
Cell Reports|March 8, 2016
Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to ApoptosisStephanie Grabow, Alex R D Delbridge, Brandon J Aubrey, et al.
Frontiers in Genetics|September 26, 2022
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune systemNirashaa T Bound, Cassandra J Vandenberg, Apriliana E R Kartikasari, et al.
Molecular Cancer Research : MCR|April 17, 2021
CHK2 Inhibition Provides a Strategy to Suppress Hematologic Toxicity from PARP InhibitorsZhen Xu, Cassandra J Vandenberg, Elizabeth Lieschke, et al.
Pageof 5